Literature DB >> 21155886

Lens culinaris agglutinin-reactive fraction of AFP is a useful prognostic biomarker for survival after repeat hepatic resection for HCC.

Masanori Matsuda1, Masami Asakawa, Hidetake Amemiya, Hideki Fujii.   

Abstract

BACKGROUND AND AIM: Repeat hepatic resection for recurrent hepatocellular carcinoma (HCC) is effective in improving long-term outcome in selected patients. In the present study, we attempted to identify the prognostic factors influencing overall and recurrence-free survival after the second hepatic resection.
METHODS: From 1 September 1997 to 30 September 2009, 329 consecutive patients with HCC underwent surgical exploration at Yamanashi University Hospital, Japan. Of these, 35 patients underwent curative, second hepatic resection. The survival results in the 35 patients were analyzed retrospectively, and prognostic factors were determined.
RESULTS: The univariate analysis revealed that Child-Pugh B, a Lens culinaris agglutinin-reactive fraction of α-fetoprotein (AFP-L3) value more than 15%, and multiple tumors, were associated with significantly worse overall survival (P=0.010, P=0.0003, and P=0.037, respectively) and only AFP-L3 >15% was associated with significantly worse recurrence-free survival after the second hepatic resection (P=0.008). By multivariate analysis, only AFP-L3 >15% was an independent predictor of adverse overall survival. The 1-, 3-, and 5-year survival rates after the second hepatic resection of 27 HCC patients with low AFP-L3 (≤15%) were 100%, 100%, and 91.7%, respectively, whereas the corresponding survival rates of eight HCC patients with high AFP-L3 (>15%) were 100%, 47.6%, and 23.8%, respectively.
CONCLUSIONS: The preoperative AFP-L3 level was a useful prognostic biomarker for survival after repeat hepatic resection.
© 2011 Journal of Gastroenterology and Hepatology Foundation and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21155886     DOI: 10.1111/j.1440-1746.2010.06532.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  10 in total

Review 1.  Current biomarkers for hepatocellular carcinoma: Surveillance, diagnosis and prediction of prognosis.

Authors:  Kerstin Schütte; Christian Schulz; Alexander Link; Peter Malfertheiner
Journal:  World J Hepatol       Date:  2015-02-27

Review 2.  Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma.

Authors:  Pei-Pei Song; Ju-Feng Xia; Yoshinori Inagaki; Kiyoshi Hasegawa; Yoshihiro Sakamoto; Norihiro Kokudo; Wei Tang
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

Review 3.  Overdiagnosis of hepatocellular carcinoma: Prevented by guidelines?

Authors:  Nicole E Rich; Amit G Singal
Journal:  Hepatology       Date:  2022-01-18       Impact factor: 17.425

4.  Clinical value of gadoxetic acid-enhanced magnetic resonance imaging in surgery for hepatocellular carcinoma - with a special emphasis on early hepatocellular carcinoma.

Authors:  Masanori Matsuda
Journal:  World J Hepatol       Date:  2015-12-28

5.  Diagnostic value of AFP-L3 and PIVKA-II in hepatocellular carcinoma according to total-AFP.

Authors:  Jong Young Choi; Seung Won Jung; Hee Yeon Kim; Myungshin Kim; Yonggoo Kim; Dong Goo Kim; Eun-Jee Oh
Journal:  World J Gastroenterol       Date:  2013-01-21       Impact factor: 5.742

6.  Early Detection of Hepatocellular Carcinoma Recurrence Using the Highly Sensitive Fucosylated Fraction of Alpha-Fetoprotein.

Authors:  Toru Setsu; Atsunori Tsuchiya; Takayuki Watanabe; Takuro Nagoya; Satoshi Ikarashi; Kazunao Hayashi; Junji Yokoyama; Satoshi Yamagiwa; Shuji Terai
Journal:  Case Rep Gastroenterol       Date:  2017-03-21

Review 7.  Biomarkers in Hepatocellular Carcinoma: Diagnosis, Prognosis and Treatment Response Assessment.

Authors:  Federico Piñero; Melisa Dirchwolf; Mário G Pessôa
Journal:  Cells       Date:  2020-06-01       Impact factor: 6.600

8.  Analysis of serum alpha-fetoprotein (AFP) and AFP-L3 levels by protein microarray.

Authors:  Min Wu; Haidong Liu; Zhaobo Liu; Chao Liu; Aiying Zhang; Ning Li
Journal:  J Int Med Res       Date:  2018-08-15       Impact factor: 1.671

9.  Accurate prediction of microvascular invasion occurrence and effective prognostic estimation for patients with hepatocellular carcinoma after radical surgical treatment.

Authors:  Yuling Xiong; Peng Cao; Xiaohua Lei; Weiping Tang; Chengming Ding; Shuo Qi; Guodong Chen
Journal:  World J Surg Oncol       Date:  2022-09-30       Impact factor: 3.253

10.  Preoperative gadoxetic Acid-enhanced MRI and simultaneous treatment of early hepatocellular carcinoma prolonged recurrence-free survival of progressed hepatocellular carcinoma patients after hepatic resection.

Authors:  Masanori Matsuda; Tomoaki Ichikawa; Hidetake Amemiya; Akira Maki; Mitsuaki Watanabe; Hiromichi Kawaida; Hiroshi Kono; Katsuhiro Sano; Utaroh Motosugi; Hideki Fujii
Journal:  HPB Surg       Date:  2014-02-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.